elvanse adult 70mg capsules
takeda uk ltd - lisdexamfetamine dimesylate - oral capsule - 70mg
elvanse 20mg capsules
takeda uk ltd - lisdexamfetamine dimesylate - oral capsule - 20mg
elvanse 40mg capsules
takeda uk ltd - lisdexamfetamine dimesylate - oral capsule - 40mg
elvanse 60mg capsules
takeda uk ltd - lisdexamfetamine dimesylate - oral capsule - 60mg
tyvense 30 milligram capsules hard
shire pharmaceutical contracts ltd - lisdexamfetamine dimesylate - capsules hard - 30 milligram - 06ba12
tyvense 70 milligram capsules hard
shire pharmaceutical contracts ltd - lisdexamfetamine dimesylate - capsules hard - 70 milligram - 06ba12
tyvense 50 milligram capsules hard
shire pharmaceutical contracts ltd - lisdexamfetamine dimesylate - capsules hard - 50 milligram - 06ba12
tyvense 20 milligram capsules hard
shire pharmaceutical contracts ltd - lisdexamfetamine dimesylate - capsules hard - 20 milligram - phenylethylamine derivatives - centrally acting sympathomimetics - it is indicated as part of a comprehensive treatment programme for attention deficit/hyperactivity disorder (adhd) in children aged 6 years and over when response to previous methylphenidate treatment is considered clinically inadequate
tyvense 40 milligram capsules hard
shire pharmaceutical contracts ltd - lisdexamfetamine dimesylate - capsules hard - 40 milligram - phenylethylamine derivatives - centrally acting sympathomimetics - it is indicated as part of a comprehensive treatment programme for attention deficit/hyperactivity disorder (adhd) in children aged 6 years and over when response to previous methylphenidate treatment is considered clinically inadequate
tyvense 60 milligram capsules hard
shire pharmaceutical contracts ltd - lisdexamfetamine dimesylate - capsules hard - 60 milligram - phenylethylamine derivatives - centrally acting sympathomimetics - it is indicated as part of a comprehensive treatment programme for attention deficit/hyperactivity disorder (adhd) in children aged 6 years and over when response to previous methylphenidate treatment is considered clinically inadequate.